| 1621/1961 | US=51 / Câncer Cohen MH. Using legal and ethical principles to guide clinical decision making in complementary/integrative cancer medicine. In: Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana Press, 2008. p. 15-32. ISBN 978-1-58829-869-0. RESPONSABILIDADE; NEGLIGENCIA MEDICA; CONSENTIMENTO INFORMADO; COMPLEMENTAR; MEDICINA ALTERNATIVA; CANCRO MEDICINA |
| 1622/1961 | US=51 / Câncer Frenkel M, Ben-Arye E. Communicating with patients about the use of complementary and integrative medicine in cancer care. In: Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana Press, 2008. p. 33-46. ISBN 978-1-58829-869-0. COMUNICACAO; INTEGRATIVA; MEDICINA; COMUNICACAO MEDICO-PACIENTE; TRATAMENTO DO CANCER; MEDICINA COMPLEMENTAR; CUIDADO CENTRADO NO PACIENTE |
| 1623/1961 | US=51 / Câncer Cohen L, Baynham-Fletcher L, Kirkwood C. The integrative medicine program at the university of texas M.D Anderson cancer center. In: Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana Press, 2008. p. 49-65. ISBN 978-1-58829-869-0. MEDICINA INTEGRATIVA; ONCOLOGIA; CUIDADO CENTRADO PACIENTE; EDUCACAO |
| 1624/1961 | US=51 / Câncer Menten K, Lee S, Dobs AS. The Johns Hopkins complementary and integrative medicine service. In: Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana Press, 2008. p. 105-21. ISBN 978-1-58829-869-0. JOHNS HOPKINS; MEDICINA INTEGRATIVA; DESAFIOS; ACUPUNTURA; MASSAGEM; MENTE-CORPO CLASSE |
| 1625/1961 | US=51 / Câncer Barton DL, Bauer BA, Loprinzi CL. Integrative oncology at mayo clinic: research informing pratice. In: Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana Press, 2008. p. 123-35. ISBN 978-1-58829-869-0. MEDICINA INTEGRATIVA; PESQUISA; EDUCACAO; ASSISTENCIA AO PACIENTE |
| 1626/1961 | US=51 / Câncer Chandwani KD, Chaoul-Reich A, Biegler KA, Cohen L. Mind-Body reseacrch in cancer. In: Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana Press, 2008. p. 139-60. ISBN 978-1-58829-869-0. MEDICINA MENTE-CORPO; ONCOLOGIA; QUALIDADE DE VIDA; IOGA; MEDITACAO; QIGONG |
| 1627/1961 | US=56 / Biol/Mol Brower SL, Fensterer JE, Bush JE. The chemoFx assay: an ex vivo chemosensitivity and resistance assay for predicting patient response to cancer chemotherapy. In: Mor G, Alvero AB. Apoptosis and cancer: methods and protocols. New Jersey: Humana Press, 2008. p. 57-78. (Methods in Molecular Biology) ISBN 978-1-58829-457-9. ENSAIO CHEMOFX; ENSAIO EX VIVO; QUIMIOSENSIBILIDADE; QUIMIOTERAPIA; QUIMIOSSENSIBILIDADE E RESISTENCIA; CULTURA DE TECIDO PRIMARIO; MEDICINA PERSONALIZADA; CANCER |
| 1628/1961 | US=3-B / Clín/Médica Hart G. Donovanose. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 991-2. ISBN 85-7726050-8. DONOVANOSE; INFECCAO BACTERIANA CRONICA; KLEBSIELLA GRANULOMATIS |
| 1629/1961 | US=64 / Câncer Heffner LT. Staging in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 3-7. (Comtemporary Hematology) ISBN 978-1-934115-82-4. MIELOMA MULTIPLO; TERAPIA-ALVO; MEDICINA TRADUCAO; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 1630/1961 | US=3-C / Clín/Médica Phillipson EA. Distúrbios da ventilação. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison medicina interna. 17ª ed. Rio de Janeiro: McGraw-Hill, 2008. p. 1661-5. ISBN 85-7726051-5. |
| 1631/1961 | US=69 / Câncer Wheler J, Kurzrock R. Perspectives: bench to bedside and back. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 1-19. ISBN 978-1-60327-423-4. TERAPIA DE CANCER DIRECIONADA; MEDICINA TRANSLACIONAL; BIOINFORMATICA; ACIDO TRANS-RETINOICO; GIST; IMATINIB; DASATINIBE; EPIGENETICA; DECITABINA; DETER HIPOTESE CELULAR |
| 1632/1961 | US=69 / Câncer Welsh SJ, Powis G. Toward personalized therapy for cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 411-25. ISBN 978-1-60327-423-4. TERAPIA PERSONALIZADA PARA O CANCER; CANCER; MEDICINA PERSONALIZADA; TERAPIA INDIVIDUALIZADA; FARMACOGENOMICA; TERAPIA-ALVO; ALVOS MOLECULARES |
| 1633/1961 | US=80 / Biol/Mol Jain KK. Tumor proteomics: oncoproteomics for personalized management of cancer. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 81-99. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. MICROARRAYS DE PROTEINA; DROGAS ANTICANCER; BIOMARKETING; CANCER; ONCOPROTEOMICS; MEDICINA PERSONALIZADA; FARMACOGENOMICA; PHARMACOPROTEOMICS; PERFIL DE PROTEINAS; PROTEOMICA |
| 1634/1961 | US=86 / Biol/Mol Zakeri Z, Lockshin RA. Cell dealth: history and future. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 1-11. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. MORTE CELULAR; APOPTOSE; AUTOFAGIA; MORTE CELULAR AUTOFAGICA; HISTORICO; LISOSSOMA |
| 1635/1961 | US=86 / Biol/Mol Salvesen GS, Riedl SJ. Caspase mechanisms. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 13-23. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. CASPASE; MECANISMOS DE CASPASE; APOPTOSSOMO; DISC; IAP; INIBICAO; PROTEASE; ZIMOGENIO; APOPTOSE |
| 1636/1961 | US=86 / Biol/Mol Chalah A, Khosravi-Far R. The mitochondrial death pathway. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 25-45. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. VIA DE MORTE MITOCONDRIAL; APOPTOSE; RECEPTORES DE MORTE; MITOCONDRIAS; MEMBRANAS; FOSFOLIPASES; CARDIOLIPINA; LIBERACAO DE FATORES PRO-APOPTOTICOS; CITOCROMO C; FATOR DE INDUCAO DE APOPTOSE; SMAC / DIABLO; HTRA2/OMI; ENDONUCLEASE G; PROTEINAS MITOCONDRIAIS; ATIVACAO DA CASPASE; FAMILIA BCL-2; STRESS OXIDATIVO; CANCER |
| 1637/1961 | US=86 / Biol/Mol Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Apoptotic pathways in tumor progression and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 47-79. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. VIAS APOPTOTICAS; PROGRESSAO TUMORAL; TERAPIA DE CANCER; APOPTOSE; INIBIDORES; TRANSDUCAO DE SINAL; ONCOGENE; MAQUINARIA APOPTOTICA; DROGAS QUIMIOTERAPICAS; RESISTENCIA A DROGA |
| 1638/1961 | US=86 / Biol/Mol Tan TT, White E. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 81-104. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. SEGMENTACAO TERAPEUTICO; VIAS DE MORTE EM CANCER; MECANISMOS; MORTE CELULAR; CELULAS CANCERIGENAS; APOPTOSE; QUIMIOTERAPIA; TERAPIA ALVO; FAMILIA BCL-2; RECEPTORES DE MORTE; INIBIDORES DO SINAL DE TRANSDUCAO |
| 1639/1961 | US=86 / Biol/Mol Hersey P, Zhang XD, Mhaidat N. Overcoming resistance to apoptosis in cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 105-26. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RESISTENCIA A APOPTOSE; ONCOGENE; MELANOMA; FAMILIA BCL-2 |
| 1640/1961 | US=86 / Biol/Mol Humphreys RC, Halpern W. Trail receptors: targets for cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 127-58. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RECEPTORES TRAIL; APOPTOSE; ANTICORPOS MONOCLONAIS |